[Federal Register Volume 60, Number 177 (Wednesday, September 13, 1995)]
[Notices]
[Pages 47585-47586]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-22693]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee (NVAC), Subcommittee on 
Vaccine Safety and the Advisory Commission on Childhood Vaccines (ACCV) 
Subcommittee on Vaccine Safety, Subcommittee on Immunization Coverage, 
and Subcommittee on Future Vaccines: Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 9 a.m.-12 noon, September 28, 1995. 8:30 a.m.-1 
p.m., September 29, 1995.
    Place: Hubert H. Humphrey Building, Room 703A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee shall advise and make recommendations to 
the Director of the National Vaccine Program on matters related to 
the Program responsibilities.
    Matters To Be Discussed: The Committee will discuss the National 
Vaccine Program Office operations and staffing; report of the Task 
Force on Safer Vaccines; status of the Advisory Committee on 
Immunization Practices reevaluation of polio immunization 
recommendations; impact of Federal budget cuts on Federal vaccine 
research; update on the Children's Immunization Initiative, 
including the Vaccines for Children Program; Mercer Report: next 
step; update on pertussis trial; status of the Salk facility; impact 
on welfare reform; subcommittee reports: vaccine safety, 
immunization coverage, and future vaccines; and a working group 
report on adult immunization.

    Name: Subcommittee on Vaccine Safety and the Advisory Commission 
on Childhood Vaccines Subcommittee on Vaccine Safety.
    Time and Date: 1:30 p.m.-5 p.m., September 28, 1995.
    Place: Hubert H. Humphrey Building, Room 337A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This joint ACCV/NVAC subcommittee will review issues 
relevant to vaccine safety and adverse reactions to vaccines.
    Matters To Be Discussed: The Subcommittee will discuss the 
Institute of Medicine vaccine safety forum and summary of planned 
workshops; summary of the final report of the task force on safer 
childhood vaccines; and the charge of the Subcommittees.

    Name: Subcommittee on Immunization Coverage.
    Time and Date: 1:30 p.m.-5 p.m., September 28, 1995.
    Place: Hubert H. Humphrey Building, Room 423A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: The Subcommittee on Immunization Coverage will identify 
strategies and policy options by which to further improve the levels 
of immunization coverage.
    Matters To Be Discussed: The Subcommittee will discuss 
determinants of under vaccination in preschool children; national, 
State, and local immunization coverage levels; current interventions 
for immunization and the future health environment.

    Name: Subcommittee on Future Vaccines.
    Time and Date: 1:30 p.m.-5 p.m., September 28, 1995.
    Place: Hubert H. Humphrey Building, Room 425A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: The Subcommittee on Future Vaccines will develop policy 
options and guide national activities which will lead to accelerated 
development, licensure, and best use of new vaccines in the simplest 
possible immunization schedules.
    Matters to be Discussed: The Subcommittee will review and 
discuss the 

[[Page 47586]]
terms of reference for the Subcommittee; identify the matrix of 
interactions and partnerships, via specific case studies; describe 
the process of priority-setting by each of the members of the 
vaccine research and development community, and define barriers to 
new vaccine development.
    Agenda items for each meeting are subject to change as 
priorities dictate.
    Contact Person for More Information: Gloria A. Kovach, Committee 
Management Specialist, National Vaccine Program Office, CDC, 1600 
Clifton Road, NE, M/S A20, Atlanta, Georgia 30333, telephone 404/
639-3851.

    Dated: September 7, 1995.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 95-22693 Filed 9-12-95; 8:45 am]
BILLING CODE 4163-18-M